Skip to main content

UD Partners with Optive Research for Grid-Based Drug Discovery

NEW YORK, Aug. 4 (GenomeWeb News) - United Devices said today that it is partnering with computer-assisted drug discovery software firm Optive Research to optimize the newly launched company's software for UD's Grid MP distributed computing platform.


The Grid MP technology - which harnesses unused computing cycles from clusters, servers, desktops, and workstations into a single computing platform - is now available with Optive's DiverseSolutions software for chemical diversity and library design, UD said.


The companies said they are also planning to provide Optive's Confort software for conformational searching and sampling, as well as its EA-Inventor software for de novo molecular design.


Further information on the partnership is available here.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.